Reneo Pharmaceuticals, Inc.

RPHM

RPHMReneo Pharmaceuticals, Inc. US flag

NASDAQ Global Market

18.20

USD

+16.47

- -

60.84MMarket Cap

Income Statement (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -
- Operating Expenses	15	20	40	54	83
+ Selling, General & Admin	2	4	12	16	26
+ Research & Development	13	16	28	38	57
+ Other Operating Expense	- -	- -	- -	- -	- -
Operating Income (Loss)	-15	-20	-40	-54	-83
- Non-Operating (Income) Loss	-3	- -	- -	-2	-6
+ Interest Expense, Net	- -	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	-3	- -	- -	-2	-6
Pretax Income	-12	-19	-40	-52	-77
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-12	-19	-40	-52	-77
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-12	-19	-40	-52	-77
- Minority Interest	- -	- -	- -	- -	- -
Net Income, GAAP	-12	-19	-40	-52	-77
- Preferred Dividends	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-12	-19	-40	-52	-77
EBIT	-15	-20	-40	-54	-83
EBITDA	-15	-20	-40	-54	-83
EBITDA Margin (%)	- -	- -	- -	- -	- -
EBITA	-15	-20	-40	-54	-83
Gross Margin (%)	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	8	24	18	24	31
Basic EPS, GAAP	-1.6	-0.8	-2.19	-2.12	-2.52
Basic EPS from Cont Ops	-1.6	-0.8	-2.19	-2.12	-2.52
Diluted Weighted Avg Shares	8	24	18	24	31
Diluted EPS, GAAP	-1.6	-0.8	-2.19	-2.12	-2.52
Diluted EPS from Cont Ops	-1.6	-0.8	-2.19	-2.12	-2.52

Balance Sheet (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	25	55	154	106	107
+ Cash, Cash Equivalents & STI	25	54	148	101	103
+ Cash & Cash Equivalents	18	54	125	20	28
+ ST Investments	7	- -	23	81	75
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -
+ Other ST Assets	1	1	6	5	4
+ Misc ST Assets	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	2	1
+ Property, Plant & Equip, Net	- -	- -	- -	2	1
+ Property, Plant & Equip	- -	- -	- -	2	1
- Accumulated Depreciation	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	- -
Total Assets	26	55	154	108	107
+ Payables & Accruals	2	4	5	6	14
+ Accounts Payable	1	1	2	2	9
+ Accrued Taxes	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -
+ Other Payables & Accruals	2	3	3	4	5
+ ST Debt	- -	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -
+ Other ST Liabilities	1	1	1	1	4
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Misc ST Liabilities	1	1	1	1	4
Total Current Liabilities	3	5	6	7	18
+ LT Debt	- -	- -	- -	1	1
+ LT Borrowings	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	1	1
+ Other LT Liabilities	46	93	1	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Misc LT Liabilities	46	93	- -	- -	- -
Total Noncurrent Liabilities	46	93	1	1	1
Total Liabilities	49	97	7	8	19
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -
+ Share Capital & APIC	2	3	232	237	307
+ Common Stock	- -	- -	- -	- -	- -
+ Additional Paid in Capital	2	3	232	237	307
- Treasury Stock	- -	- -	- -	- -	- -
+ Retained Earnings	-25	-45	-85	-137	-218
+ Other Equity	- -	- -	- -	- -	- -
Equity Before Minority Interest	-23	-42	147	100	89
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
Total Equity	-23	-42	147	100	89
Total Liabilities & Equity	26	55	154	108	107
Shares Outstanding	24	24	24	25	33
Number of Employees	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	1	1
Net Debt	-18	-54	-125	-20	-28
Net Debt to Equity	75.67	127.3	-84.68	-19.93	-31.18
Tangible Common Equity Ratio	-90.68	-76.27	95.58	92.41	82.48
Current Ratio	8.64	12.01	24.79	14.93	5.87
Cash Conversion Cycle	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-12	-19	-40	-52	-77
+ Depreciation & Amortization	- -	- -	- -	- -	- -
+ Non-Cash Items	-2	- -	5	4	1
+ Stock-Based Compensation	- -	- -	4	4	5
+ Deferred Income Taxes	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	1
+ Other Non-Cash Adj	-2	- -	1	-1	-4
+ Chg in Non-Cash Work Cap	2	1	-3	1	12
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	1	-1	-5	1	2
+ Inc (Dec) in Accts Payable	1	1	2	1	11
+ Inc (Dec) in Other	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Operating Activities	-13	-19	-38	-47	-64
+ Change in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	85	- -	60
+ Increase in Capital Stock	- -	- -	85	- -	65
+ Decrease in Capital Stock	- -	- -	- -	- -	-4
+ Net Change in LT Investment	-7	7	-23	-57	11
+ Dec in LT Investment	13	7	8	44	242
+ Inc in LT Investment	-20	- -	-31	-102	-231
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Investing Activities	-7	7	-23	-58	11
+ Dividends Paid	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -
+ Other Financing Activities	25	47	48	- -	1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Financing Activities	25	47	132	- -	61
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -
Net Changes in Cash	5	36	71	-105	8
EBITDA	-15	-20	-40	-54	-83
EBITDA Margin (%)	- -	- -	- -	- -	- -
Free Cash Flow	-13	-19	-38	-48	-64
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-19	-38	-48	-64
Free Cash Flow per Basic Share	-1.61	-0.77	-2.1	-1.95	-2.08
Price/Free Cash Flow	- -	- -	-41.06	-12.14	-7.73
Cash Flow to Net Income	1.01	0.95	0.96	0.91	0.82
Capital Expenditures	- -	- -	- -	- -	- -